PTCT
PTCT
NASDAQ · Biotechnology

Ptc Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$73.31
+2.46 (+3.47%)
As of Aug 7, 8:11 PM ET ·
PTCT vs Biotechnology Average
P/E Ratio
PTCT 792.6
Avg 33.2
Profit Margin
PTCT 39.4%
Avg -193.5%
Rev Growth
PTCT +128.3%
Avg +14.8%

Biotechnology Peers

1012 stocks in sector
Symbol Name Price Change % Market Cap P/E Margin Growth Div Yield Analyst
PTCT Ptc Therapeutics Inc $73.31 +3.47% 5.85B 792.6 39.4% +128.3% — Current
ABBV Abbvie Inc $245.22 +0.55% 446.67B 122.9 6.9% +1.8% 2.69% Strong buy Compare
AMGN Amgen Inc $407.95 +0.77% 206.48B 26.5 21.0% +11.8% 2.60% Hold Compare
GILD Gilead Sciences Inc $133.75 +2.21% 161.72B 17.6 28.9% +2.6% 2.50% Strong buy Compare
VRTX Vertex Pharmaceuticals Inc $484.53 -0.06% 120.52B 27.8 32.9% +10.4% — Strong buy Compare
REGN Regeneron Pharmaceuticals $782.10 +1.29% 77.36B 17.5 31.4% +5.6% 0.51% Buy Compare
RVMD Revolution Medicines Inc $201.71 +1.97% 39.87B — 4.4% +0.4% — Strong buy Compare
NTRA Natera Inc $319.63 +20.44% 38.31B — -9.0% +41.1% — Strong buy Compare
BIIB Biogen Inc $206.56 +0.14% 30.34B 22.1 13.1% -0.9% — Buy Compare
ALNY Alnylam Pharmaceuticals Inc $217.68 +0.72% 27.52B 47.7 8.5% +53.0% — Strong buy Compare
ROIV Roivant Sciences Ltd $36.26 +3.25% 24.83B — -3,629.2% -48.7% — Strong buy Compare
INCY Incyte Corp $120.39 +1.70% 24.31B 15.1 25.0% +14.8% — Hold Compare
UTHR United Therapeutics Corp $529.54 +2.03% 22.11B 17.2 41.9% +18.0% — Strong buy Compare
MRNA Moderna Inc $58.35 +8.34% 21.75B — -145.2% -53.4% — Hold Compare
INSM Insmed Inc $131.40 -0.87% 21.12B — -210.5% +35.2% — Strong buy Compare
EXAS Exact Sciences Corp $104.91 +0.95% 20.03B — -6.4% +15.9% — Hold Compare
NBIX Neurocrine Biosciences Inc $164.27 +2.78% 16.78B 25.1 16.7% +24.3% — Strong buy Compare
BBIO Bridgebio Pharma Inc $84.63 +2.21% 15.70B — -144.4% +86.3% — Strong buy Compare
EXEL Exelixis Inc $53.77 +3.01% 13.44B 16.1 33.7% +12.9% — Hold Compare
ARWR Arrowhead Pharmaceuticals In $87.44 +1.88% 12.07B — -0.2% +50.5% — Strong buy Compare
BMRN Biomarin Pharmaceutical Inc $64.11 +4.31% 11.58B 43.1 10.8% +15.4% — Strong buy Compare